Reliable information about vaccines

Tick-borne encephalitis

Tick-borne encephalitis (TBE) vaccine is given in the National Vaccination Program for all people over the age of three who are long-term permanent residents or those who reside long-term in holiday apartments in risk areas of the tick-borne encephalitis. Outside the risk areas you can take the vaccine at your own expense or it may be included in your occupational health care.

Hepatitis A

The Hepatitis A vaccine is provided free of charge in the national vaccination program to individuals with hemophilia who receive regular treatment, people who inject drugs and their close contacts, and men who have sex with men. The vaccine is also recommended for individuals with chronic liver disease, carriers of the hepatitis C and hepatitis B viruses, and individuals who are exposed to hepatitis A infection through their work or who travel to areas where hepatitis A is prevalent.

Hepatitis B

The Hepatitis B vaccine is provided free of charge in the national vaccination program to individuals with hemophilia who receive regular treatment, people who inject drugs and their close contacts, and men who have sex with men. Due to the increased risk of the disease, the vaccine is also provided free of charge to, among others, household members of individuals with Hepatitis B infection and students at risk of infection during internships. The vaccine is also recommended for dialysis patients and, as needed, for travelers.

The renewed Lääkeinfo.fi service has now been launched!

The need for reliable information on medicines is greater than ever before. The package leaflets available in the Lääkeinfo.fi service are official and approved by medicines authorities and they are for medicinal products sold in Finland.

💊 Lääkeinfo.fi – a trusted source of information for nearly 20 years.

Pneumococcus

Pneumococci are a significant cause of severe bacterial infections, like meningitis and sepsis, in Finland. The pneumococcal vaccine is included in the National Immunisation Programme for young children, patients who have received stem cell treatment, to those under 75 years of age who are severely immunocompromised or suffer from severe nephrotic disease and to 65-84 years old patients with asthma or chronic obstructive pulmonary disease (COPD). It is additionally recommended for people belonging to certain medical risk groups. 